Literature DB >> 7818244

Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.

H C Hendrie1, K S Hall, S Hui, F W Unverzagt, C E Yu, D K Lahiri, A Sahota, M Farlow, B Musick, C A Class.   

Abstract

As part of a community-based study of Alzheimer's disease (AD) in the African-American population age 65 and over, we have determined apolipoprotein E (Apo E) genotypes in 85 subjects (31 AD patients and 54 controls). The epsilon 4 allele of Apo E was strongly associated with AD in this population sample. The epsilon 4 allele frequency in AD patients was 40.3% compared with 13.9% in the control group, and 22.6% of the AD patients were homozygous for this allele compared with 3.7% of the control subjects (p = 0.01). This study extends the association of Apo E-epsilon 4 and AD to nonwhite populations and provides further evidence that the observed allelic association is biologically relevant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7818244     DOI: 10.1002/ana.410370123

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  24 in total

Review 1.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

Review 2.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample.

Authors:  Kumar B Rajan; Elizabeth A McAninch; Robert S Wilson; Jennifer Weuve; Lisa L Barnes; Denis A Evans
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Authors:  Jessica B S Langbaum; Kewei Chen; Richard J Caselli; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Christine M Burns; Alfred W Kaszniak; Stephanie A Reeder; Jason J Corneveaux; April N Allen; Jeremy Pruzin; Matthew J Huentelman; Adam S Fleisher; Eric M Reiman
Journal:  Arch Neurol       Date:  2010-04

Review 5.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample.

Authors:  Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Jennifer Weuve; Elizabeth A McAninch; Denis A Evans
Journal:  J Am Geriatr Soc       Date:  2018-12-24       Impact factor: 5.562

7.  Semantic network function captured by word frequency in nondemented APOE ε4 carriers.

Authors:  Jet M J Vonk; Roxanna J Flores; Dayanara Rosado; Carolyn Qian; Raquel Cabo; Josina Habegger; Karmen Louie; Elizabeth Allocco; Adam M Brickman; Jennifer J Manly
Journal:  Neuropsychology       Date:  2018-11-29       Impact factor: 3.295

8.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

9.  Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.

Authors:  Z Hawi; K Sheehan; A Lynch; I Evans; N Lowe; B Lawlor; M Gill
Journal:  Ir J Med Sci       Date:  2003 Apr-Jun       Impact factor: 1.568

10.  Association of apolipoprotein E genotype and Alzheimer disease in African Americans.

Authors:  Jill R Murrell; Brandon Price; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Adesola Ogunniyi; Frederick W Unverzagt; Valerie Smith-Gamble; Sujuan Gao; Hugh C Hendrie; Kathleen S Hall
Journal:  Arch Neurol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.